(Q59309192)

English

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

phase I clinical trial

1 reference

based on heuristic

inferred from title

Silvia Ratto-Kim

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Deborah L. Birx

15

object named as

D Birx

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

John R. Mascola

11

object named as

J R Mascola

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

S Nitayaphan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C Khamboonruang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Sirisophana

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Morgan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Chiu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A M Duliege

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C Chuenchitra

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Supapongse

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K Rungruengthanakit

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M deSouza

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K Boggio

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L E Markowitz

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

V Suriyanon

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J G McNeil

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A E Brown

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R A Michael

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1448-1455

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

The 100% condom program in Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Declining prevalence of HIV-1 infection in young Thai men.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic comparison of HIV-1 isolates from Africa, Europe, and North America

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Nationwide surveillance of HIV-1 prevalence and subtype in young Thai men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900421-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(99)00421-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10618542%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q59309192&oldid=1749513660"